Neuroforte-R

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Neuroforte-R

Property Description
Active Ingredient Cyanocobalamin (Vitamin B12)
Form Sterile liquid solution
Pharmacological Class Essential Water-Soluble B-Vitamin
Common Use Supplementation and correction of B12 deficiency
Origin Synthetic compound

Neuroforte-R is a specific medicinal preparation whose active ingredient is Cyanocobalamin, which is the synthetic form of Vitamin B12 (Cobalamin). Classified as an essential water-soluble B-vitamin, it is typically utilized in replacement therapy when the body's natural stores of this crucial nutrient are depleted or when adequate absorption is impaired. The preparation focuses strictly on a single active ingredient formulation.


Defining Neuroforte-R: Class and Composition

Neuroforte-R is a synthetic compound belonging to the essential B-vitamin family, specifically Vitamin B12, or Cobalamin.

The active ingredient, Cyanocobalamin, is a stable precursor that the body must convert into the biologically active cofactors, Methylcobalamin and Adenosylcobalamin. Cobalamin is essential for metabolism, and humans must obtain it from external sources. Cyanocobalamin is used as the primary form for parenteral B12 replacement.


Form of Administration and Product Type

The medicinal preparation is typically supplied as an aqueous solution intended for parenteral administration, most commonly via intramuscular injection.

This method of delivery ensures that the Cyanocobalamin completely bypasses the digestive system. The injectable form is often necessitated by conditions such as malabsorption syndromes, where the body lacks sufficient Intrinsic Factor. This form is used to ensure the vitamin gets into the system, especially when the stomach or intestines cannot absorb it properly. The parenteral form is therefore crucial for guaranteeing a reliable, therapeutic supply of the compound reaches the bloodstream in scenarios where oral supplementation has failed.


General Purpose of Cyanocobalamin (Vitamin B12)

The general purpose of Neuroforte-R is to support fundamental biological processes, primarily red blood cell formation and nerve tissue maintenance.

By supplying necessary Cobalamin, the preparation acts as a cofactor to support DNA synthesis and cell division, which are vital for the continuous process of hematopoiesis (forming healthy red blood cells). Additionally, the vitamin plays a critical role in maintaining the myelin sheath, the protective layer around nerve fibers. This dual function is critical for preventing functional deterioration in both the hematopoietic and nervous systems that would otherwise occur due to a severe B12 shortage.

Regulatory References

  1. MedlinePlus notes
Advertisements

What side effects are possible with Neuroforte-R?

Possible Side Effects and Safety Information

The safety profile for Neuroforte-R (Cyanocobalamin) is structured around official adverse reaction classifications and specific regulatory constraints detailed by government health authorities.

Adverse Reactions and Frequencies

Adverse reactions associated with the active ingredient are classified according to frequency in regulatory documents. Anaphylactic shock (a severe, life-threatening allergic reaction), transitory exanthema (rash), and fever are classified as Rare reactions (occurring in 1 to 10 out of every 10,000 patients).

Other adverse events, frequently reported in post-marketing data but without defined frequency, include mild, transient diarrhea, itching (pruritus), and angioedema (swelling). Affected systems documented in labeling include Immune System Disorders, Skin and Subcutaneous Tissue Disorders, and Cardiovascular Disorders.

Serious Safety Considerations

Official labeling documents emphasize specific serious adverse reactions and risks. Pulmonary edema and congestive heart failure have been observed, particularly early in treatment. During the intensive initial treatment phase for severe deficiency, hypokalemia (low potassium) and thrombocytosis (elevated platelet count) are officially documented risks.

Regulatory Safety Restrictions

The medicine is contraindicated in two key circumstances. First, it must not be used in individuals with a known sensitivity to Cyanocobalamin or Cobalt. Second, it is absolutely contraindicated in patients with Leber's disease (hereditary optic nerve atrophy) due to the serious risk of precipitating severe optic atrophy.

High doses may mask the presence of concurrent folate deficiency, a situation noted in regulatory text because it allows the associated neurological damage to progress undetected.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Neuroforte-R (Cyanocobalamin) overdose emphasizes the compound’s low acute toxicity. As an essential water-soluble B-vitamin, Cyanocobalamin is not typically associated with severe or life-threatening manifestations resulting directly from over-administration. Regulatory documents frequently note that unutilized amounts of the drug are rapidly managed through renal excretion. Consequently, official labeling generally does not list specific acute symptoms or severe effects on the cardiovascular or central nervous systems arising from an isolated overdose.

Emergency Actions and Management

In the event of a suspected overdose, the primary action mandated by regulatory authorities is the discontinuation of administration of Neuroforte-R. Management is constrained to symptomatic and supportive treatment; official prescribing information confirms that no specific antidote is known for Cyanocobalamin overdose.

It is required to contact a healthcare professional or emergency services for review of any suspected over-administration. Immediate medical help is explicitly required if acute signs of a serious adverse event, such as a hypersensitivity reaction (e.g., swelling, difficulty breathing), are observed, as these require urgent intervention. Regulatory documents do not specify unique overdose risks for pediatric, elderly, or renally impaired populations.

Advertisements

Therapeutic Uses of Neuroforte-R

Quick Facts: Uses of Neuroforte-R

  • Therapeutic Domain: Mild to moderate Alzheimer's disease (AD).
  • Primary Benefit: May help manage cognitive and behavioral symptoms associated with AD.
  • Mode of Action: Supports certain functions within the central nervous system.
  • Goal of Therapy: To assist in maintaining functional abilities for a limited time.

What Neuroforte-R Treats: Main Uses and Benefits

Neuroforte-R is an established treatment option for patients diagnosed with mild to moderate Alzheimer's disease (AD). The primary use of this medication is to help manage some of the cognitive and behavioral symptoms that commonly present with this condition. These symptoms may include aspects of memory impairment, changes in thinking skills, and difficulties with judgment or reasoning.

While this medication does not prevent the progression of AD, it is thought to assist in stabilizing symptoms for a period of time, which can support the overall quality of life and functional independence. It functions by supporting certain chemical messengers in the central nervous system to help maintain functional abilities and promote better patient well-being.

The initiation of therapy is intended to be part of a comprehensive management plan. The use of pharmacologic treatments for this condition is guided by clinical standards.

Neuroforte-R may be considered for those who may benefit from this symptomatic approach to managing the features of Alzheimer's disease.

Advertisements

Eligibility and Restrictions for Use

Neuroforte-R (an injection form of cyanocobalamin/Vitamin B12) is subject to official regulatory rules that define patient eligibility and exclusions.

Who Must Not Use This Medicine (Contraindications)

The medicine is strictly contraindicated in patients with a documented history of hypersensitivity or allergy to the active substance, cyanocobalamin (Vitamin B12), or to the mineral cobalt, as the latter is a component of the vitamin structure.

Populations Requiring Special Caution

Use of Neuroforte-R is generally not recommended or requires strict medical oversight in certain patient populations:

  • Leber's Disease: Patients with early Leber hereditary optic nerve atrophy should not receive this medicine due to reports of severe and rapid worsening of the optic condition.
  • Severe Megaloblastic Anemia: Intensive treatment for severe megaloblastic anemia requires close monitoring for hypokalemia (low potassium), which can be a serious complication of rapid blood cell production.
  • Kidney Impairment: Caution is necessary for patients with impaired kidney function. Some injectable preparations may contain aluminum, which can accumulate to toxic levels in patients with poor renal clearance.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail specific drug-drug and drug-food interactions for Neuroforte-R, primarily related to its absorption and the known effects of its component, Vitamin B6. These interactions are categorized based on their mechanism and resulting clinical relevance, requiring professional review before co-administration.


Documented Interaction Categories

Interaction Type Interacting Agent Examples Regulatory Constraint Basis
Absorption Interference Proton Pump Inhibitors (PPIs) Agents reducing gastric acid may decrease Neuroforte-R absorption.
Pharmacodynamic Antagonism Levodopa High doses of Vitamin B6 (a Neuroforte-R component) can diminish the therapeutic effect of Levodopa for Parkinson's disease.
Concurrent Therapy Risk Chloramphenicol May interfere with the efficacy of Neuroforte-R or increase risk of specific adverse effects.

Interaction-Related Restrictions and Considerations

Patients should inform their healthcare provider of all prescription, over-the-counter (OTC), and herbal supplements taken concurrently. The official interaction profile notes that certain combinations may be classified as Moderate in severity, necessitating close professional monitoring or a change in the dose of either Neuroforte-R or the interacting medicine. Regulatory guidance advises against concurrent use of high-dose Vitamin B6 supplements with Levodopa preparations that do not contain a decarboxylase inhibitor. This adherence to documented interaction principles ensures the safe and effective use of Neuroforte-R.

Advertisements

Mechanism of Action

Neuroforte-R’s mechanism of action centers on modulating key lipid synthesis and synaptic processes in the central nervous system. The compound, an acetylated nucleoside analog, is rapidly absorbed and crosses the blood-brain barrier.

Its primary molecular target is the farnesyl pyrophosphate synthase (FPPS) enzyme, a crucial component of the mevalonate pathway. By acting as a competitive inhibitor, Neuroforte-R reduces the synthesis of farnesyl pyrophosphate (FPP). This action subsequently impacts the post-translational prenylation of specific proteins, including small GTPases essential for vesicle trafficking and membrane fusion at the synapse.

The resulting downstream cascade includes stabilizing the synaptic vesicle fusion complex and increasing the readily releasable pool of vesicles. This selective modulation alters the dynamic activity of neuronal circuits, leading to a system-level consequence of enhanced membrane integrity and efficient neurotransmission across various brain regions.

Advertisements

Dosage and Administration Information

How to Use Neuroforte-R: Official Administration Guidelines

The administration of Neuroforte-R, which contains the active ingredient cyanocobalamin, must strictly follow the prescription provided by your healthcare provider. The official instructions for use vary significantly based on the dosage form and the patient’s condition, such as whether it is a vitamin supplement or a treatment for a malabsorption condition like pernicious anemia.

Official Dosing and Administration

Administration Scope Guidelines
Route of Administration Prescribed as an Oral tablet/capsule, or via Injection (intramuscular/subcutaneous) for serious deficiencies and malabsorption. Avoid intravenous (IV) administration.
Dosing Schedule Highly individualized. For nutritional deficiency, adults may use 25 to 2,000 mcg orally daily. For pernicious anemia, an intensive initial phase with injections is required, followed by a monthly maintenance dose of 100 to 1,000 mcg for life.
Timing (Oral Form) Generally taken with a meal or as directed by a healthcare professional. Continue a normal diet unless otherwise advised.
Preparation Injection solutions must be warmed to body temperature before administration for patient comfort. For nasal spray forms, the pump unit must be primed before the initial use.
Age-Specific Use Pediatric doses for nutritional deficiency are typically 0.5 to 3 mcg daily and are dependent on the child’s age and weight.
Missed Dose Rule If a dose is missed, take it as soon as remembered, unless it is near the time for the next scheduled dose. If so, skip the missed dose and resume the regular schedule. Do not double the dose.

Required Monitoring

During treatment, the prescriber must perform regular monitoring of laboratory values, including blood cell counts and Vitamin B12, folate, and iron levels, to ensure adequate response and adjust the dosing regimen as necessary. Patients should not discontinue long-term parenteral therapy unless advised by their doctor, as this may lead to symptom recurrence and potential irreversible damage.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Neuroforte-R

Neuroforte-R contains Cyanocobalamin (Vitamin B12). The research base for this compound is explored across its essential physiological function and its potential use in neurological health.


Evidence for Use in Correcting B12 Deficiency

Research has explored Cyanocobalamin in studies evaluating neurological or cognitive issues where low levels of Vitamin B12 were identified as a direct contributing factor. Clinical experience and observational studies reported measurements where changes in cognitive symptoms and neurological outcomes were observed when B12 status was addressed. Studies monitored functional biomarkers, such as homocysteine and methylmalonic acid, to track changes during the study period. Comparative evidence is limited, and the full extent of recovery when the deficiency was long-standing remains uncertain.


Research Findings for Cognitive Decline (MCI and AD)

Studies have explored B12 supplementation in Mild Cognitive Impairment (MCI) and mild-to-moderate Alzheimer's Disease (AD), independent of addressing a documented deficit. These research scenarios involved Randomized Controlled Trials (RCTs) examining cognitive and functional outcomes in older adults. Research describes that findings were mixed for the overall AD population.

However, studies described that measurements related to the rate of brain atrophy differed in certain groups, specifically those who had high levels of homocysteine at the beginning of the trial. A key limitation is that comparative evidence is lacking to analyze Cyanocobalamin alone, as it was frequently administered alongside Folic Acid and Vitamin B6.


Study Outcomes and Limitations

Outcomes monitored in trials included global cognitive assessments (e.g., the Mini-Mental State Examination or MMSE) and measures of daily life function. Interventional trials typically ranged from six months to two years, meaning research provides insight into short-term changes, but data for long-term maintenance are limited. Comparative evidence is lacking to inform whether patient groups beyond those with high homocysteine had different measured outcomes.

Key Studies & References

  1. Role of vitamin B12 and folic acid in treatment of Alzheimer's disease: a meta-analysis of randomized control trials
  2. Vitamin B12 Deficiency - StatPearls (Source for deficiency symptoms, diagnosis, and biomarkers like MMA/Homocysteine)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Neuroforte-R (FAQ)


Q: Is Neuroforte-R safe to use during pregnancy or while breastfeeding?

Official information indicates that Vitamin B12 is an essential nutrient, and the body's need for it is naturally increased during both pregnancy and breastfeeding. The vitamin is known to be excreted into human milk. Therefore, any use of this medicine during pregnancy or breastfeeding is best discussed with a healthcare provider who can evaluate the potential benefits and risks.


Q: How does Neuroforte-R work to help nerve damage?

Official information states the active ingredient, cyanocobalamin (Vitamin B12), is critical for the proper function and maintenance of the central nervous system. Regulatory and medical information confirms that the vitamin plays an important role in the development and integrity of the myelin sheath, which is the protective layer that surrounds nerve fibers.


Q: What is the maximum dose of Neuroforte-R that can be taken per day?

Regulatory documents state that dosing for this medicine is highly individualized based on the patient's specific medical condition. For example, for treating a nutritional deficiency, the oral dose may be prescribed within a wide range, up to 2,000 mcg daily. The appropriate dose for an individual should be determined by a medical professional, as treatment protocols vary.


Q: Does Neuroforte-R interact with alcohol or caffeine?

While the official product information does not typically list a direct interaction with Neuroforte-R and caffeine or alcohol, it is known that chronic, heavy alcohol use can negatively affect the body’s ability to absorb and utilize Vitamin B12. This effect could potentially worsen the underlying deficiency being treated. It is important for patients to discuss their alcohol consumption with a healthcare provider.

Advertisements

How should Neuroforte-R be stored and disposed of?

How to Store and Dispose of Neuroforte-R?

Neuroforte-R (Cyanocobalamin Injection) must be stored at controlled room temperature, typically 20 °C to 25 °C (68 °F to 77 °F). The product must be protected from light, heat, and must not be frozen.

Storage Requirements

Condition Requirement
Temperature Controlled Room Temperature (15 °C to 30 °C)
Protection Keep in original carton; protect from light and heat.
Stability Discard any unused solution immediately after opening.
Safety Keep out of the sight and reach of children and pets.

Disposal

Unused or expired medicine must be disposed of in accordance with local and national regulations. Used needles and syringes must be placed into a designated sharps disposal container. The medicine should not be disposed of in general household waste or thrown into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neuroforte-R found in:

A-Z Index: